Jabinal, Raihana S.

HRN: 23-59-17  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2024
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
10/10/2024
10/17/2024
PO
1
Q8h
URTI, Ecthyma
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: